Tu-mor(e) blood cells from human pluripotent stem cells.

Studies by Amabile et al reported in this issue of Blood use a novel strategy of teratoma formation from human induced pluripotent stem cells (iPSCs) to isolate hematopoietic stem/progenitor cells (HSPCs) capable of in vivo engraftment and producing functional lymphocytes.(1)

• Publication year

  2013

• Venue

  Blood

• Publication date

  2013-02-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2013-01-472563PMID 23429981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

  2013cited by this paper
• RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

  2012cited by this paper
• Lessons from human teratomas to guide development of safe stem cell therapies

  2012cited by this paper
• T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.

  2012cited by this paper
• Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells.

  2008cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• Hematopoietic Engraftment of Human Embryonic Stem Cell‐Derived Cells Is Regulated by Recipient Innate Immunity

  2006cited by this paper
• Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression

  2005cited by this paper
• Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients.

  2004cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper

• CRISPR to fix bad blood: a new tool in basic and clinical hematology

  2019cites this paper
• Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications.

  2014cites this paper